HEATHER DAIGLE: Open Payments
NPI 1427282284 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 69 payments from 20 companies in 2025. Trend: 2023 $676 · 2024 $1,024 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $209 |
| AstraZeneca Pharmaceuticals LP | 9 | $151 |
| Lilly USA, LLC | 11 | $137 |
| PFIZER INC. | 5 | $92 |
| Kowa Pharmaceuticals America, Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Edwards Lifesciences Corporation | 2 | $46 |
| Seqirus USA Inc | 2 | $41 |
| Ardelyx, Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
Products named: AIRSUPRA, Wegovy, MOUNJARO, Ozempic, REXULTI, PREVNAR 20, ZORYVE, IBSRELA.
Industry payments across LA — which companies pay providers there.
